 periop methotrex vinblastin doxorubicin cisplatin m-vac poor risk transit cell carcinoma bladder eastern cooper oncolog group pilot studi total patient advanc transit cell carcinoma bladder underw preoper cycl chemotherapi methotrex vinblastin doxorubicin cisplatin radic cystectomi postop cycl chemotherapi radic cystectomi patient patholog partial respons patholog complet respons over-al respons rate confid median followup patient evid recurr diseas metastat bladder cancer averag rel dose intens therapi hematolog toxic moder septic death complic thromboembol event primari bladder tumor periop schedul result impress find incid thromboembol event worrisom